# Spark Ventures

> Spark Ventures is a VC fund in London backing Software and Hardware. See 21 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: London, United Kingdom
- Total investments: 21
- Last investment: Mar 2021
- Lead investor: 14%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/spark-venture-management
- Website: http://www.sparkventuremanagement.com

Spark Ventures is a VC fund in London focused on Software and Hardware. SPARK Ventures, formerly NewMediaSpark, is an early-stage venture capital investor in Europe, providing equity investment to high growth technology, media and healthcare companies in the UK and Europe. SPARK Ventures has been investing in early-stage businesses for 12 years and has a wealth of expertise in backing and developing companiesfrom start-up through to eventual trade sale or IPO.

## Contacts

5 contacts available for Spark Ventures. Shizune tracks 6 team members at Spark Ventures. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/spark-ventures?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $1.5M–$14M |
| Series B | $5M–$16M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 6 | 29% |
| Hardware | 3 | 14% |
| Biotechnology | 3 | 14% |
| Information Technology | 3 | 14% |
| Medical | 2 | 10% |

43 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Funding Round | 7 | 33% |
| Series B | 4 | 19% |
| Series A | 3 | 14% |
| Seed | 1 | 5% |
| Angel | 1 | 5% |

7 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United Kingdom | 12 | 57% |
| United States | 2 | 10% |
| India | 1 | 5% |
| Australia | 1 | 5% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Kiko Duffy | Founder and Investment Director | 1 | https://shizune.co/investors/profile/kiko-duffy |
| Thomas Teichman | Chairman and Executive Director | 6 | https://shizune.co/investors/profile/tom-teichman |
| Andy Betton | Financial Director | 0 | https://shizune.co/investors/profile/andy-betton |
| Jonathan Gee | Investment Director | 0 | https://shizune.co/investors/profile/jonathan-gee |
| Martin Williams | Director | 0 | https://shizune.co/investors/profile/martin-williams-2 |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Unmarshal | Unmarshal is a Decentralized network of blockchain data indexers and transforming tools to power DeFi applications on any chain. | $2.6M | Seed | Mar 19, 2021 |  |
| Simba Sleep | Simba Sleep is an e-commerce company that offers a variety of mattresses. It brings together thousands of super-light comfort springs and support from precision-engineered foam in perfect harmony.The company is driven by a mission is to bring the importance of sleep back into focus, and help everyone wake up winning. Simba Sleep was founded in2015 and is headquartered in London, England. | $1.5M | Series A | Feb 10, 2016 |  |
| Haemostatix | Based at BioCity, Nottingham, UK, Haemostatix Ltd was co-founded in 2003 by Sarah Middleton and Professor Alison Goodall as a spin-out from the University of Leicester. The Company was established to commercialise a new technology platform based upon a specific peptide sequence that binds to fibrinogen – a protein essential to the formation ofclots. The peptide is coupled to different forms of solid support or soluble carriers to create both topical and systemic haemostats. This new technology platform is the basis of a pipeline of first-in-class products to treat various forms of bleeding in surgery, trauma and in leukaemic patients. | $2.9M |  | Nov 02, 2012 |  |
| Oxford Immunotec | Oxford Immunotec is a medical diagnostics company developing novel new tests for various diseases based on its innovative, patented T cell measurement technology. The company's first product is a TB test that diagnoses latent TB infection ( LTBI ) and TB disease. T-SPOT®.TB is an interferon gamma release assay ( IGRA ) which are designed toreplace the century old Mantoux skin test ( TST ). | $28M |  | Jun 18, 2012 |  |
| Celoxica | Based in London, United Kingdom, Celoxica delivers latency market data access and order execution solutions to the advanced trading community. The company’s solutions include a full range of market data feed handlers for the main U.S. and European equities, options, futures exchanges, and FX. With clients that include trading firms who co-locatetheir strategic applications in high frequency trading environments, market making, liquidity provision, algorithmic trading, and smart order routing, the company also offers a single access point for brokers and their clients by handling inbound FIX, credit check, and outbound native protocol to the execution venues. Celoxica was founded in 1996. | $842K |  | May 08, 2012 |  |
| Haemostatix | Based at BioCity, Nottingham, UK, Haemostatix Ltd was co-founded in 2003 by Sarah Middleton and Professor Alison Goodall as a spin-out from the University of Leicester. The Company was established to commercialise a new technology platform based upon a specific peptide sequence that binds to fibrinogen – a protein essential to the formation ofclots. The peptide is coupled to different forms of solid support or soluble carriers to create both topical and systemic haemostats. This new technology platform is the basis of a pipeline of first-in-class products to treat various forms of bleeding in surgery, trauma and in leukaemic patients. |  | Series C | Aug 01, 2011 |  |
| Haemostatix | Based at BioCity, Nottingham, UK, Haemostatix Ltd was co-founded in 2003 by Sarah Middleton and Professor Alison Goodall as a spin-out from the University of Leicester. The Company was established to commercialise a new technology platform based upon a specific peptide sequence that binds to fibrinogen – a protein essential to the formation ofclots. The peptide is coupled to different forms of solid support or soluble carriers to create both topical and systemic haemostats. This new technology platform is the basis of a pipeline of first-in-class products to treat various forms of bleeding in surgery, trauma and in leukaemic patients. | $601K |  | Nov 11, 2010 |  |
| Celoxica | Based in London, United Kingdom, Celoxica delivers latency market data access and order execution solutions to the advanced trading community. The company’s solutions include a full range of market data feed handlers for the main U.S. and European equities, options, futures exchanges, and FX. With clients that include trading firms who co-locatetheir strategic applications in high frequency trading environments, market making, liquidity provision, algorithmic trading, and smart order routing, the company also offers a single access point for brokers and their clients by handling inbound FIX, credit check, and outbound native protocol to the execution venues. Celoxica was founded in 1996. | $1.4M |  | Aug 10, 2010 |  |
| Academia.edu | Academia.edu is the largest and fastest-growing platform in the world for sharing academic research. Its mission is to accelerate and democratize academic research. Over 150 million academics have signed up to Academia.edu, adding 25 million papers. Over 100,000 people join Academia.edu each day. Academia.edu attracts over 52 million uniquevisitors a month. 40% of the world's faculty log in to Academia.edu every month. The company was founded in 2008 and is headquartered in San Francisco, California. | $1.6M | Angel | Apr 28, 2010 |  |
| Celona Technologies | Celona Technologies Ltd. provides business centric application data migration software that drives business changes for organizations. It offers a suite of purpose built software solutions that enable applications, data, users, and processes to be migrated within a zero downtime environment; Celona Evolve, which manages the migration and thebi-directional synchronization of application data and business processes simultaneously, as well as provides management dashboard, business migration console, migration scheduler, reports and audit trail, and exception management solutions; and Application Adaptors, which enables the plug-in of either single or multiple business application adaptors when migrating data from a legacy source to a new application target or domain. It serves billing, CRM, ERP, inventory management, and legacy systems applications; and telecoms, financial services, utilities, retailing, and public sector industries. The company was formerly known as Sceales-Endacott Systems Integration Limited and changed its name to Celona Technologies Ltd. in January 2005. Celona Technologies Ltd. was founded in 2005 and is based in London, the United Kingdom with additional offices in Europe and the Asia Pacific. | $3.2M |  | Feb 02, 2010 |  |

10 of 21 investments shown.

## Co-investors
- [Catapult Ventures](https://shizune.co/investors/profile/catapult-venture-managers) — VC Fund, 4 deals together
- [Nesta Ventures](https://shizune.co/investors/profile/nesta-investments) — VC Fund, 4 deals together
- [Accel](https://shizune.co/investors/profile/accel) — VC Fund, 2 deals together
- [Credit Suisse](https://shizune.co/investors/profile/credit-suisse) — VC Fund, 2 deals together
- [Esperante Ventures](https://shizune.co/investors/profile/esperante-ventures) — VC Fund, 2 deals together
- [Herald Ventures](https://shizune.co/investors/profile/herald-ventures) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Everywhere Ventures](https://shizune.co/investors/profile/everywhere-ventures) — VC Fund
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund

### Similar stage
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund

### Similar country
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Artesian VC](https://shizune.co/investors/profile/artesian-capital-management) — VC Fund
- [Blackbird Ventures](https://shizune.co/investors/profile/blackbird-ventures-australia) — VC Fund

## Featured in investor lists
- [Medical Investors in United Kingdom](https://shizune.co/investors/medical-investors-united-kingdom)
- [Medical VC Funds in United Kingdom](https://shizune.co/investors/medical-vc-funds-united-kingdom)
- [Energy Investors in Australia](https://shizune.co/investors/energy-investors-australia)
- [Energy VC Funds in Australia](https://shizune.co/investors/energy-vc-funds-australia)
- [Sustainability Investors in Australia](https://shizune.co/investors/sustainability-investors-australia)
- [Sustainability VC Funds in Australia](https://shizune.co/investors/sustainability-vc-funds-australia)

## FAQ

### What does Spark Ventures invest in?

Spark Ventures invests primarily in Software, Hardware and Biotechnology startups, most often at Funding Round and Series B stage. Most of the 21 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Spark Ventures's check size?

Spark Ventures typically joins rounds of $1.5M–$14M at Series A and $5M–$16M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Spark Ventures participates in.

### How do I contact Spark Ventures?

Public channels for Spark Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Spark Ventures?

The team at Spark Ventures includes Kiko Duffy (Founder and Investment Director), Thomas Teichman (Chairman and Executive Director) and Andy Betton (Financial Director), among 6 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co